US 2021/0228490 A1Published application

Stable pharmaceutical formulation

AssigneeOryzon Genomics, S.A.

InventorsReto MAURER, Patrick BUSSON, Georg HUMMEL

Life of this patent

Estimating the term…

Abstract

The present invention relates to a pharmaceutical composition of (trans)-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine, a process for the preparation thereof and its use in the treatment of diseases.

Claims22

Dependent claims

A pharmaceutical composition comprising a compound of formula I,

or a pharmaceutically acceptable salt thereof, a complexing agent and an antioxidant.

Dependencies are inferred from the claim text.

Facts

Application: 17/051,540Filed 6 May 2019
Priority: EP 18170938.74 May 2018
Published: 29 Jul 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 9/284
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
A61K 9/5026
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/2009
Excipients; Inactive ingredients: inorganic compounds

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results